-
1
-
-
78650090584
-
Changing patterns of ST elevation myocardial infarction epidemiology
-
Bolognese L. Changing patterns of ST elevation myocardial infarction epidemiology. Am Heart J. 2010;160:S1-S3.
-
(2010)
Am Heart J
, vol.160
, pp. S1-S3
-
-
Bolognese, L.1
-
2
-
-
84860275301
-
Clinical epidemiology, management and outcome of acute coronary syndromes in the Italian network on acute coronary syndromes (IN-ACS Outcome study)
-
IN-ACS Outcome Investigators
-
Rizzello V, Lucci D, Maggioni AP, Giampaoli S, Greco C, Di Pasquale G, Pallotti MG, Mureddu GF, Di Chiara A, Boccanelli A; IN-ACS Outcome Investigators. Clinical epidemiology, management and outcome of acute coronary syndromes in the Italian network on acute coronary syndromes (IN-ACS Outcome study). Acute Card Care. 2012;14:71-80. doi: 10.3109/17482941.2012.655296.
-
(2012)
Acute Card Care
, vol.14
, pp. 71-80
-
-
Rizzello, V.1
Lucci, D.2
Maggioni, A.P.3
Giampaoli, S.4
Greco, C.5
Di Pasquale, G.6
Pallotti, M.G.7
Mureddu, G.F.8
Di Chiara, A.9
Boccanelli, A.10
-
3
-
-
0025681542
-
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing
-
Hunninghake DB, Mellies MJ, Goldberg AC, Kuo PT, Kostis JB, Schrott HG, Insull W Jr, Pan HY. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing. Atherosclerosis. 1990;85:219-227.
-
(1990)
Atherosclerosis
, vol.85
, pp. 219-227
-
-
Hunninghake, D.B.1
Mellies, M.J.2
Goldberg, A.C.3
Kuo, P.T.4
Kostis, J.B.5
Schrott, H.G.6
Insull, W.7
Pan, H.Y.8
-
4
-
-
0025792042
-
The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group
-
Rubenfire M, Maciejko JJ, Blevins RD, Orringer C, Kobylak L, Rosman H. The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group. Arch Intern Med. 1991;151:2234-2240.
-
(1991)
Arch Intern Med
, vol.151
, pp. 2234-2240
-
-
Rubenfire, M.1
MacIejko, J.J.2
Blevins, R.D.3
Orringer, C.4
Kobylak, L.5
Rosman, H.6
-
5
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
6
-
-
0031018962
-
Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease
-
Andrews TC, Raby K, Barry J, Naimi CL, Allred E, Ganz P, Selwyn AP. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 1997;95:324-328.
-
(1997)
Circulation
, vol.95
, pp. 324-328
-
-
Andrews, T.C.1
Raby, K.2
Barry, J.3
Naimi, C.L.4
Allred, E.5
Ganz, P.6
Selwyn, A.P.7
-
7
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators
-
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med. 1996;335:1001-1009. doi: 10.1056/NEJM199610033351401.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.9
Wun, C.C.10
Davis, B.R.11
Braunwald, E.12
-
8
-
-
58949105089
-
Relation of statin therapy to risk of heart failure after acute myocardial infarction
-
Aronson D, Mutlak D, Lessick J, Kapeliovich M, Dabbah S, Markiewicz W, Beyar R, Hammerman H, Reisner S, Agmon Y. Relation of statin therapy to risk of heart failure after acute myocardial infarction. Am J Cardiol. 2008;102:1706-1710. doi: 10.1016/j.amjcard.2008.07.057.
-
(2008)
Am J Cardiol
, vol.102
, pp. 1706-1710
-
-
Aronson, D.1
Mutlak, D.2
Lessick, J.3
Kapeliovich, M.4
Dabbah, S.5
Markiewicz, W.6
Beyar, R.7
Hammerman, H.8
Reisner, S.9
Agmon, Y.10
-
9
-
-
65449152570
-
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction
-
IDEAL Study Group
-
Strandberg TE, Holme I, Faergeman O, Kastelein JJ, Lindahl C, Larsen ML, Olsson AG, Pedersen TR, Tikkanen MJ; IDEAL Study Group. Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction. Am J Cardiol. 2009;103:1381-1385. doi: 10.1016/j.amjcard.2009.01.377.
-
(2009)
Am J Cardiol
, vol.103
, pp. 1381-1385
-
-
Strandberg, T.E.1
Holme, I.2
Faergeman, O.3
Kastelein, J.J.4
Lindahl, C.5
Larsen, M.L.6
Olsson, A.G.7
Pedersen, T.R.8
Tikkanen, M.J.9
-
10
-
-
0031298186
-
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
-
Kjekshus J, Pedersen TR, Olsson AG, Faergeman O, Pyörälä K. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail. 1997;3:249-254.
-
(1997)
J Card Fail
, vol.3
, pp. 249-254
-
-
Kjekshus, J.1
Pedersen, T.R.2
Olsson, A.G.3
Faergeman, O.4
Pyörälä, K.5
-
11
-
-
33846879844
-
Effect of high-dose atorvastatin on hospitalizations for heart failure: Subgroup analysis of the Treating to New Targets (TNT) study
-
Khush KK, Waters DD, Bittner V, Deedwania PC, Kastelein JJ, Lewis SJ, Wenger NK. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation. 2007;115:576-583. doi: 10.1161/CIRCULATIONAHA.106.625574.
-
(2007)
Circulation
, vol.115
, pp. 576-583
-
-
Khush, K.K.1
Waters, D.D.2
Bittner, V.3
Deedwania, P.C.4
Kastelein, J.J.5
Lewis, S.J.6
Wenger, N.K.7
-
12
-
-
0032508533
-
Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
-
Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998;273:24266-24271.
-
(1998)
J Biol Chem
, vol.273
, pp. 24266-24271
-
-
Laufs, U.1
Liao, J.K.2
-
13
-
-
0032745205
-
Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis
-
Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol. 1999;26:903-908.
-
(1999)
Clin Exp Pharmacol Physiol
, vol.26
, pp. 903-908
-
-
Luo, J.D.1
Zhang, W.W.2
Zhang, G.P.3
Guan, J.X.4
Chen, X.5
-
14
-
-
84856221255
-
Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta
-
Brili S, Tousoulis D, Antonopoulos AS, Antoniades C, Hatzis G, Bakogiannis C, Papageorgiou N, Stefanadis C. Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta. Heart. 2012;98:325-329. doi: 10.1136/heartjnl-2011-300287.
-
(2012)
Heart
, vol.98
, pp. 325-329
-
-
Brili, S.1
Tousoulis, D.2
Antonopoulos, A.S.3
Antoniades, C.4
Hatzis, G.5
Bakogiannis, C.6
Papageorgiou, N.7
Stefanadis, C.8
-
15
-
-
31844451010
-
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
-
Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4:977-987. doi: 10.1038/nrd1901.
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 977-987
-
-
Jain, M.K.1
Ridker, P.M.2
-
16
-
-
84874474015
-
Statins suppress apolipoprotein CIIIinduced vascular endothelial cell activation and monocyte adhesion
-
Zheng C, Azcutia V, Aikawa E, Figueiredo JL, Croce K, Sonoki H, Sacks FM, Luscinskas FW, Aikawa M. Statins suppress apolipoprotein CIIIinduced vascular endothelial cell activation and monocyte adhesion. Eur Heart J. 2013;34:615-624. doi: 10.1093/eurheartj/ehs271.
-
(2013)
Eur Heart J
, vol.34
, pp. 615-624
-
-
Zheng, C.1
Azcutia, V.2
Aikawa, E.3
Figueiredo, J.L.4
Croce, K.5
Sonoki, H.6
Sacks, F.M.7
Luscinskas, F.W.8
Aikawa, M.9
-
17
-
-
0037133338
-
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction
-
Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, Wen J, Takeshita A. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation. 2002;105:868-873.
-
(2002)
Circulation
, vol.105
, pp. 868-873
-
-
Hayashidani, S.1
Tsutsui, H.2
Shiomi, T.3
Suematsu, N.4
Kinugawa, S.5
Ide, T.6
Wen, J.7
Takeshita, A.8
-
18
-
-
30344455355
-
Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level
-
Bleske BE, Nicklas JM, Bard RL, Brook RD, Gurbel PA, Bliden KP, Rajagopalan S, Pitt B. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level. J Am Coll Cardiol. 2006;47:338-341. doi: 10.1016/j.jacc.2005.06.087.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 338-341
-
-
Bleske, B.E.1
Nicklas, J.M.2
Bard, R.L.3
Brook, R.D.4
Gurbel, P.A.5
Bliden, K.P.6
Rajagopalan, S.7
Pitt, B.8
-
19
-
-
0035964390
-
Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction
-
Bauersachs J, Galuppo P, Fraccarollo D, Christ M, Ertl G. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation. 2001;104:982-985.
-
(2001)
Circulation
, vol.104
, pp. 982-985
-
-
Bauersachs, J.1
Galuppo, P.2
Fraccarollo, D.3
Christ, M.4
Ertl, G.5
-
20
-
-
36549030340
-
Rosuvastatin in older patients with systolic heart failure
-
CORONA Group
-
Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357:2248-2261. doi: 10.1056/NEJMoa0706201.
-
(2007)
N Engl J Med
, vol.357
, pp. 2248-2261
-
-
Kjekshus, J.1
Apetrei, E.2
Barrios, V.3
Böhm, M.4
Cleland, J.G.5
Cornel, J.H.6
Dunselman, P.7
Fonseca, C.8
Goudev, A.9
Grande, P.10
Gullestad, L.11
Hjalmarson, A.12
Hradec, J.13
Jánosi, A.14
Kamenský, G.15
Komajda, M.16
Korewicki, J.17
Kuusi, T.18
MacH, F.19
Mareev, V.20
McMurray, J.J.21
Ranjith, N.22
Schaufelberger, M.23
Vanhaecke, J.24
Van Veldhuisen, D.J.25
Waagstein, F.26
Wedel, H.27
Wikstrand, J.28
more..
-
21
-
-
53049095795
-
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial
-
Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1231-9.
-
(2008)
Lancet
, vol.372
, pp. 1231-1239
-
-
Tavazzi, L.1
Maggioni, A.P.2
Marchioli, R.3
Barlera, S.4
Franzosi, M.G.5
Latini, R.6
Lucci, D.7
Nicolosi, G.L.8
Porcu, M.9
Tognoni, G.10
-
22
-
-
72649093079
-
Heart failure registry: A valuable tool for improving the management of patients with heart failure
-
Jonsson A, Edner M, Alehagen U, Dahlström U. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12:25-31. doi: 10.1093/eurjhf/hfp175.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 25-31
-
-
Jonsson, A.1
Edner, M.2
Alehagen, U.3
Dahlström, U.4
-
23
-
-
84888174958
-
Accuracy of death certificates of cardiovascular disease in a community intervention in Sweden
-
Eriksson A, Stenlund H, Ahlm K, Boman K, Bygren LO, Johansson LA, Olofsson BO, Wall S, Weinehall L. Accuracy of death certificates of cardiovascular disease in a community intervention in Sweden. Scand J Public Health. 2013;41:883-889. doi: 10.1177/1403494813499653.
-
(2013)
Scand J Public Health
, vol.41
, pp. 883-889
-
-
Eriksson, A.1
Stenlund, H.2
Ahlm, K.3
Boman, K.4
Bygren, L.O.5
Johansson, L.A.6
Olofsson, B.O.7
Wall, S.8
Weinehall, L.9
-
24
-
-
79958058102
-
External review and validation of the Swedish national inpatient register
-
Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. doi: 10.1186/1471-2458-11-450.
-
(2011)
BMC Public Health
, vol.11
, pp. 450
-
-
Ludvigsson, J.F.1
Andersson, E.2
Ekbom, A.3
Feychting, M.4
Kim, J.L.5
Reuterwall, C.6
Heurgren, M.7
Olausson, P.O.8
-
25
-
-
23744456871
-
The validity of a diagnosis of heart failure in a hospital discharge register
-
Ingelsson E, Arnlöv J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 2005;7:787-791. doi: 10.1016/j.ejheart.2004.12.007.
-
(2005)
Eur J Heart Fail
, vol.7
, pp. 787-791
-
-
Ingelsson, E.1
Arnlöv, J.2
Sundström, J.3
Lind, L.4
-
26
-
-
3543135271
-
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
-
D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
-
(1998)
Stat Med
, vol.17
, pp. 2265-2281
-
-
D'Agostino, R.B.1
-
27
-
-
84949193513
-
Reducing bias in observational studies using subclassification on the propensity score
-
Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Statist Assoc. 1984;79:516-524.
-
(1984)
J Am Statist Assoc
, vol.79
, pp. 516-524
-
-
Rosenbaum, P.R.1
Rubin, D.B.2
-
28
-
-
79961226937
-
Multivariate and propensity score matching software with automated balance optimization: The matching package for R
-
Sekhon J. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J Stat Softw. 2011;42:1-52.
-
(2011)
J Stat Softw
, vol.42
, pp. 1-52
-
-
Sekhon, J.1
-
29
-
-
0034932301
-
Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes
-
Ikeda U, Shimpo M, Ikeda M, Minota S, Shimada K. Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J Cardiovasc Pharmacol. 2001;38:69-77.
-
(2001)
J Cardiovasc Pharmacol
, vol.38
, pp. 69-77
-
-
Ikeda, U.1
Shimpo, M.2
Ikeda, M.3
Minota, S.4
Shimada, K.5
-
30
-
-
34548476976
-
Usefulness of hydrophilic vs lipophilic statins after acute myocardial infarction: Subanalysis of MUSASHI-AMI
-
MUSASHI-AMI Investigators
-
Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, Sakaino N, Kitagawa A; MUSASHI-AMI Investigators. Usefulness of hydrophilic vs lipophilic statins after acute myocardial infarction: subanalysis of MUSASHI-AMI. Circ J. 2007;71:1348-1353.
-
(2007)
Circ J
, vol.71
, pp. 1348-1353
-
-
Sakamoto, T.1
Kojima, S.2
Ogawa, H.3
Shimomura, H.4
Kimura, K.5
Ogata, Y.6
Sakaino, N.7
Kitagawa, A.8
-
31
-
-
84907800562
-
Effects of lipophilic statins for heart failure: A meta-analysis of 13 randomised controlled trials
-
Liu G, Zheng XX, Xu YL, Lu J, Hui RT, Huang XH. Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials. Heart Lung Circ. 2014;23:970-977. doi: 10.1016/j.hlc.2014.05.005.
-
(2014)
Heart Lung Circ
, vol.23
, pp. 970-977
-
-
Liu, G.1
Zheng, X.X.2
Xu, Y.L.3
Lu, J.4
Hui, R.T.5
Huang, X.H.6
-
32
-
-
84901695453
-
Effect of rosuvastatin on repeat heart failure hospitalizations: The CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)
-
Rogers JK, Jhund PS, Perez AC, Böhm M, Cleland JG, Gullestad L, Kjekshus J, van Veldhuisen DJ, Wikstrand J, Wedel H, McMurray JJ, Pocock SJ. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC Heart Fail. 2014;2:289-297. doi: 10.1016/j.jchf.2013.12.007.
-
(2014)
JACC Heart Fail
, vol.2
, pp. 289-297
-
-
Rogers, J.K.1
Jhund, P.S.2
Perez, A.C.3
Böhm, M.4
Cleland, J.G.5
Gullestad, L.6
Kjekshus, J.7
Van Veldhuisen, D.J.8
Wikstrand, J.9
Wedel, H.10
McMurray, J.J.11
Pocock, S.J.12
-
33
-
-
79955162230
-
The persistent exclusion of older patients from ongoing clinical trials regarding heart failure
-
Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, Clarfield AM, Crome P, Hertogh C, Lesauskaite V, Prada GI, Szczerbinska K, Topinkova E, Sinclair-Cohen J, Edbrooke D, Mills GH. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171:550-556. doi: 10.1001/archinternmed.2011.31.
-
(2011)
Arch Intern Med
, vol.171
, pp. 550-556
-
-
Cherubini, A.1
Oristrell, J.2
Pla, X.3
Ruggiero, C.4
Ferretti, R.5
Diestre, G.6
Clarfield, A.M.7
Crome, P.8
Hertogh, C.9
Lesauskaite, V.10
Prada, G.I.11
Szczerbinska, K.12
Topinkova, E.13
Sinclair-Cohen, J.14
Edbrooke, D.15
Mills, G.H.16
-
34
-
-
62949201759
-
Statin therapy and clinical outcomes in heart failure: A propensity-matched analysis
-
Ouzounian M, Tu JV, Austin PC, Chong A, Liu PP, Lee DS. Statin therapy and clinical outcomes in heart failure: a propensity-matched analysis. J Card Fail. 2009;15:241-248. doi: 10.1016/j.cardfail.2008.10.026.
-
(2009)
J Card Fail
, vol.15
, pp. 241-248
-
-
Ouzounian, M.1
Tu, J.V.2
Austin, P.C.3
Chong, A.4
Liu, P.P.5
Lee, D.S.6
-
35
-
-
84863474472
-
Statins in heart failure: The paradox between large randomized clinical trials and real life
-
Gastelurrutia P, Lupón J, de Antonio M, Urrutia A, Diéz C, Coll R, Altimir S, Bayes-Genis A. Statins in heart failure: the paradox between large randomized clinical trials and real life. Mayo Clin Proc. 2012;87:555-560. doi: 10.1016/j.mayocp.2012.02.018.
-
(2012)
Mayo Clin Proc
, vol.87
, pp. 555-560
-
-
Gastelurrutia, P.1
Lupón, J.2
De Antonio, M.3
Urrutia, A.4
Diéz, C.5
Coll, R.6
Altimir, S.7
Bayes-Genis, A.8
-
36
-
-
34249687159
-
Statins and symptomatic chronic systolic heart failure: A post-hoc analysis of 5010 patients enrolled in Val-HeFT
-
Krum H, Latini R, Maggioni AP, Anand I, Masson S, Carretta E, Ingrillì F, Pettinati G, Glazer R, Tognoni G, Cohn J. Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT. Int J Cardiol. 2007;119:48-53. doi: 10.1016/j. ijcard.2006.07.106.
-
(2007)
Int J Cardiol
, vol.119
, pp. 48-53
-
-
Krum, H.1
Latini, R.2
Maggioni, A.P.3
Anand, I.4
Masson, S.5
Carretta, E.6
Ingrillì, F.7
Pettinati, G.8
Glazer, R.9
Tognoni, G.10
Cohn, J.11
-
37
-
-
84897970506
-
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-S45.
-
(2014)
Circulation
, vol.129
, pp. S1-S45
-
-
Stone, N.J.1
Robinson, J.G.2
Lichtenstein, A.H.3
Bairey Merz, C.N.4
Blum, C.B.5
Eckel, R.H.6
Goldberg, A.C.7
Gordon, D.8
Levy, D.9
Lloyd-Jones, D.M.10
McBride, P.11
Schwartz, J.S.12
Shero, S.T.13
Smith, S.C.14
Watson, K.15
Wilson, P.W.16
Eddleman, K.M.17
Jarrett, N.M.18
Labresh, K.19
Nevo, L.20
Wnek, J.21
Anderson, J.L.22
Halperin, J.L.23
Albert, N.M.24
Bozkurt, B.25
Brindis, R.G.26
Curtis, L.H.27
Demets, D.28
Hochman, J.S.29
Kovacs, R.J.30
Ohman, E.M.31
Pressler, S.J.32
Sellke, F.W.33
Shen, W.K.34
Smith, S.C.35
Tomaselli, G.F.36
more..
-
38
-
-
79955760903
-
2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American college of cardiology foundation/American heart association task force on practice guidelines
-
2011 Writing Group Members; ACCF/AHA Task Force Members
-
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr; 2011 Writing Group Members; ACCF/AHA Task Force Members. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123:e426-e579. doi: 10.1161/CIR.0b013e318212bb8b.
-
(2011)
Circulation
, vol.123
, pp. e426-e579
-
-
Anderson, J.L.1
Adams, C.D.2
Antman, E.M.3
Bridges, C.R.4
Califf, R.M.5
Casey, D.E.6
Chavey, I.I.W.E.7
Fesmire, F.M.8
Hochman, J.S.9
Levin, T.N.10
Lincoff, A.M.11
Peterson, E.D.12
Theroux, P.13
Wenger, N.K.14
Wright, R.S.15
Smith, S.C.16
-
39
-
-
84886260869
-
2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
-
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, Vander Wall EE, Vrints CJ, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
-
(2013)
Eur Heart J
, vol.34
, pp. 2949-3003
-
-
Montalescot, G.1
Sechtem, U.2
Achenbach, S.3
Andreotti, F.4
Arden, C.5
Budaj, A.6
Bugiardini, R.7
Crea, F.8
Cuisset, T.9
Di Mario, C.10
Ferreira, J.R.11
Gersh, B.J.12
Gitt, A.K.13
Hulot, J.S.14
Marx, N.15
Opie, L.H.16
Pfisterer, M.17
Prescott, E.18
Ruschitzka, F.19
Sabaté, M.20
Senior, R.21
Taggart, D.P.22
Vander Wall, E.E.23
Vrints, C.J.24
Zamorano, J.L.25
Achenbach, S.26
Baumgartner, H.27
Bax, J.J.28
Bueno, H.29
Dean, V.30
Deaton, C.31
Erol, C.32
Fagard, R.33
Ferrari, R.34
Hasdai, D.35
Hoes, A.W.36
Kirchhof, P.37
Knuuti, J.38
Kolh, P.39
Lancellotti, P.40
Linhart, A.41
Nihoyannopoulos, P.42
Piepoli, M.F.43
Ponikowski, P.44
Sirnes, P.A.45
Tamargo, J.L.46
Tendera, M.47
Torbicki, A.48
Wijns, W.49
Windecker, S.50
Knuuti, J.51
Valgimigli, M.52
Bueno, H.53
Claeys, M.J.54
Donner-Banzhoff, N.55
Erol, C.56
Frank, H.57
Funck-Brentano, C.58
Gaemperli, O.59
Gonzalez-Juanatey, J.R.60
Hamilos, M.61
Hasdai, D.62
Husted, S.63
James, S.K.64
Kervinen, K.65
Kolh, P.66
Kristensen, S.D.67
Lancellotti, P.68
Maggioni, A.P.69
Piepoli, M.F.70
Pries, A.R.71
Romeo, F.72
Rydén, L.73
Simoons, M.L.74
Sirnes, P.A.75
Steg, P.G.76
Timmis, A.77
Wijns, W.78
Windecker, S.79
Yildirir, A.80
Zamorano, J.L.81
more..
-
40
-
-
84866675521
-
Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: A propensity-matched inception cohort clinical effectiveness study
-
Patel K, Fonarow GC, Kitzman DW, Aban IB, Love TE, Allman RM, Gheorghiade M, Ahmed A. Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study. Eur J Heart Fail. 2012;14:1179-1188. doi: 10.1093/eurjhf/hfs101.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 1179-1188
-
-
Patel, K.1
Fonarow, G.C.2
Kitzman, D.W.3
Aban, I.B.4
Love, T.E.5
Allman, R.M.6
Gheorghiade, M.7
Ahmed, A.8
|